Validation of a pediatric caregiver diary to measure symptoms of postacute respiratory syncytial virus bronchiolitis
- 27 April 2005
- journal article
- clinical trial
- Published by Wiley in Pediatric Pulmonology
- Vol. 40 (1) , 31-38
Abstract
Acute respiratory syncytial virus (RSV)‐induced bronchiolitis is often associated with continuing respiratory symptoms following hospitalization. To date, there is no validated objective measure to evaluate symptoms of RSV‐induced bronchiolitis. We report on the reliability, validity, and responsiveness of the bronchiolitis caregiver diary (BCD) of symptoms and healthcare utilization associated with postacute RSV. The BCD measures four symptoms (daytime cough, wheeze, trouble breathing, and nighttime cough), healthcare utilization, and rescue medication for worsening of lung symptoms. Data from the 4‐week treatment period of the reported prospective, placebo‐controlled trial of montelukast for treatment of postacute RSV were used to assess reliability (internal consistency and test‐retest), construct validity (cross‐sectional and longitudinal correlations), discriminant validity (known‐groups analyses), and responsiveness. The primary outcome of this study was the percentage of symptom‐free days (SFD). The secondary outcome was a composite symptom score (CSS; average of daytime cough, wheezing, and trouble breathing). Cronbach's alpha of 0.85 indicated that the four symptoms were internally consistent, supporting a unidimensional scale structure. Test‐retest reliabilities for the percentage of SFD and CSS were above the recommended cut point of 0.70. Cross‐sectional and longitudinal correlations were sizeable and statistically significant, demonstrating construct validity. Hypothesized known‐group differences were statistically significant in the appropriate direction. Responsiveness analyses indicated moderate effect sizes for percentage of SFD. In conclusion, the BCD provides a valid, reliable, and responsive tool for the assessment of symptoms of postacute RSV‐induced bronchiolitis, capable of measuring moderate effect sizes, and demonstrating responsiveness to therapy.Keywords
This publication has 10 references indexed in Scilit:
- A Randomized Trial of Montelukast in Respiratory Syncytial Virus PostbronchiolitisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999The Pediatric Infectious Disease Journal, 2002
- Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 YearsPediatrics, 2001
- Validation of a pediatric asthma caregiver diaryJournal of Allergy and Clinical Immunology, 2000
- Bronchiolitis-associated hospitalizations among American Indian and Alaska Native childrenThe Pediatric Infectious Disease Journal, 2000
- Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996JAMA, 1999
- Validation of an asthma symptom diary for interventional studiesArchives of Disease in Childhood, 1999
- Reproducibility and responsiveness of health status measures statistics and strategies for evaluationControlled Clinical Trials, 1991
- Measuring change over time: Assessing the usefulness of evaluative instrumentsJournal of Chronic Diseases, 1987
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951